Skip to main content

EDMOND DE ROTHSCHILD HOLDING S.A.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1649647 Chambesy, V8

Position in REGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$357,911
+$336,348 QoQ
Shares Held
574
+1588.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#890
of 1,322 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2024
CallValue
$122,740
CallShares
3,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EDMOND DE ROTHSCHILD HOLDING S.A. holds $84,636,966 across 13 Biotechnology names. REGN ranks #13 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $357,911 574
2025-03-31 $21,563 34
2024-12-31 $24,219 34
2024-09-30 $35,742 34
2024-06-30 $40,990 39
2024-03-31 $114,536 119
2024-03-31 $122,740 3,400
2023-12-31 $97,490 111
2023-09-30 $100,401 122
2023-06-30 $94,128 131
2023-03-31 $135,575 165
2022-12-31 $188,308 261
2022-09-30 $164,639 239
2022-06-30 $289,652 490
2022-03-31 $1,706,937 2,444
2021-12-31 $2,800,158 4,434
2021-09-30 $3,202,006 5,291
2021-06-30 $2,602,795 4,660
2021-03-31 $3,333,742 7,046
2020-12-31 $3,223,309 6,672
2020-09-30 $4,033,213 7,205
2020-06-30 $4,675,503 7,497
2020-03-31 $23,926 49